Saran Saund - Chief Business Officer at Oncotelic Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
OTLC on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Saran Saund since 9/19/2023

Holdings reported by Saran Saund for Oncotelic Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16.5M $428K $0.03 Jul 8, 2021 Direct
Stock Options 675K Sep 3, 2021 Direct Common Stock
Series A Convertible Preferred Stock 0 Mar 31, 2021 Direct Common Stock

Transactions reported by Saran Saund for Oncotelic Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.